PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 2281418

  • 1. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI, Stavskaia VV, Sheveleva LA.
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [Abstract] [Full Text] [Related]

  • 2. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Biriukova LS, Makurov AI.
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract] [Full Text] [Related]

  • 3. [Some problems of the therapy of chronic glomerulonephritis].
    Riabov SI, Stavskaia VV.
    Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
    [Abstract] [Full Text] [Related]

  • 4. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Varshavskiĭ VA, Biriukova LS, Stenina II.
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [Abstract] [Full Text] [Related]

  • 5. [Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
    Hruby Z.
    Przegl Lek; 1992; 49(1-2):28-30. PubMed ID: 1455001
    [No Abstract] [Full Text] [Related]

  • 6. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 7. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa, Fedorova ND.
    Urol Nefrol (Mosk); 1996 Dec; (2):32-5. PubMed ID: 8677550
    [Abstract] [Full Text] [Related]

  • 8. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL, Sidorova LD, Valentik MF, Movchan EA, Savitskaia IV, Nekipelova VI, Dorofeev SB, Nesina IA.
    Ter Arkh; 1990 Dec; 62(6):37-42. PubMed ID: 2218924
    [Abstract] [Full Text] [Related]

  • 9. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Dec; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 10. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Dec; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 11. [Treatment results in various morphological patterns of glomerulonephritis].
    Riabov SI, Stavskaia VV.
    Ter Arkh; 1984 Dec; 56(9):97-101. PubMed ID: 6515557
    [Abstract] [Full Text] [Related]

  • 12. [The prognosis of the accelerated progression of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Varshavskiĭ VA, Stenina II, Slutskin IM.
    Ter Arkh; 1992 Dec; 64(3):116-9. PubMed ID: 1440256
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 14. [The effect of treatment on the survival rate in chronic glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Aug; 29(6):29-35. PubMed ID: 2091380
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of membranous glomerulonephritis].
    Stavskaia VV, Riabov SI.
    Ter Arkh; 1985 Aug; 57(6):74-8. PubMed ID: 4071419
    [Abstract] [Full Text] [Related]

  • 16. [Factors influencing the results of chronic glomerulonephritis treatment].
    Riabov SI, Stavskaia VV, Chistova EK, Ashkinazi RI, Zaitseva NI, Kravchenko NP, Mozgovaia AN, Sashurina SN.
    Klin Med (Mosk); 1997 Aug; 75(2):38-42. PubMed ID: 9157214
    [Abstract] [Full Text] [Related]

  • 17. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Aug; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

  • 18. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG.
    J Nephrol; 2007 Aug; 20(2):234-45. PubMed ID: 17514629
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE, Gordovskaia NB, Gladskikh OP, Ivanov AA, Krasnova TN.
    Ter Arkh; 1989 Aug; 61(6):9-14. PubMed ID: 2799726
    [Abstract] [Full Text] [Related]

  • 20. [Recurrence of idiopathic membranous glomerulopathy].
    Knotková V, Nĕmecek K, Ivasková E, Kupková L.
    Cas Lek Cesk; 1990 Oct 05; 129(40):1261-5. PubMed ID: 2257570
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.